Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1992 1
1993 1
1994 1
1995 1
1996 1
1997 3
1998 1
2004 1
2005 1
2006 2
2007 4
2008 6
2009 4
2010 9
2011 4
2012 5
2013 5
2014 8
2015 5
2016 6
2017 7
2018 9
2019 7
2020 4
2021 11
2022 19
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Reply.
Ten Brinke A, Steuten J, van Ham SM. Ten Brinke A, et al. Among authors: van ham sm. J Allergy Clin Immunol. 2024 Jan;153(1):354-355. doi: 10.1016/j.jaci.2023.09.034. Epub 2023 Oct 20. J Allergy Clin Immunol. 2024. PMID: 37865900 No abstract available.
Distinct dynamics of antigen-specific induction and differentiation of different CD11c+Tbet+ B-cell subsets.
Steuten J, Bos AV, Kuijper LH, Claireaux M, Olijhoek W, Elias G, Duurland MC, Jorritsma T, Marsman C, Paul AGA, Garcia Vallejo JJ, van Gils MJ, Wieske L, Kuijpers TW, Eftimov F, van Ham SM, Ten Brinke A; T2B Consortium. Steuten J, et al. Among authors: van ham sm. J Allergy Clin Immunol. 2023 Sep;152(3):689-699.e6. doi: 10.1016/j.jaci.2023.02.020. Epub 2023 Feb 27. J Allergy Clin Immunol. 2023. PMID: 36858158 Free article.
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
van Dam KPJ, Volkers AG, Wieske L, Stalman EW, Kummer LYL, van Kempen ZLE, Killestein J, Tas SW, Boekel L, Wolbink GJ, van der Kooi AJ, Raaphorst J, Takkenberg RB, D'Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Sanchez AP, van Els CACM, de Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart RCF, Teng YKO, van Paassen P, Busch MH, Jallah PBP, Brusse E, van Doorn PA, Baars AE, Hijnen DJ, Schreurs CRG, van der Pol WL, Goedee HS, Steenhuis M, Keijzer S, Keijser JBD, Cristianawati O, Ten Brinke A, Verstegen NJM, van Ham SM, Rispens T, Kuijpers TW, Löwenberg M, Eftimov F; T2B! Immunity against SARS-CoV-2 study group. van Dam KPJ, et al. Among authors: van ham sm. BMC Infect Dis. 2023 May 17;23(1):332. doi: 10.1186/s12879-023-08298-6. BMC Infect Dis. 2023. PMID: 37198536 Free PMC article.
Ways Forward for Tolerance-Inducing Cellular Therapies- an AFACTT Perspective.
Ten Brinke A, Martinez-Llordella M, Cools N, Hilkens CMU, van Ham SM, Sawitzki B, Geissler EK, Lombardi G, Trzonkowski P, Martinez-Caceres E. Ten Brinke A, et al. Among authors: van ham sm. Front Immunol. 2019 Feb 22;10:181. doi: 10.3389/fimmu.2019.00181. eCollection 2019. Front Immunol. 2019. PMID: 30853957 Free PMC article. Review.
119 results